Prognostic significance of epidermal growth factor receptor in locally advanced esophageal squamous cell carcinoma for patients receiving chemoradiotherapy (Q37652493)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 February 2014

edit

Language	Label	Description	Also known as
English	Prognostic significance of epidermal growth factor receptor in locally advanced esophageal squamous cell carcinoma for patients receiving chemoradiotherapy	scientific article published on 13 February 2014

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

3961334

retrieved

21 August 2017

title

Prognostic significance of epidermal growth factor receptor in locally advanced esophageal squamous cell carcinoma for patients receiving chemoradiotherapy (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

3961334

retrieved

21 August 2017

main subject

chemoradiotherapy

0 references

esophageal squamous cell carcinoma

1 reference

based on heuristic

inferred from title

squamous cell carcinoma

1 reference

based on heuristic

inferred from title

author

Jinming Yu

series ordinal

5

object named as

Jinming Yu

1 reference

stated in

Europe PubMed Central

PMC publication ID

3961334

retrieved

21 August 2017

Xindong Sun

series ordinal

4

object named as

Xindong Sun

1 reference

stated in

Europe PubMed Central

PMC publication ID

3961334

retrieved

21 August 2017

Xue Meng

series ordinal

2

object named as

Xue Meng

1 reference

stated in

Europe PubMed Central

PMC publication ID

3961334

retrieved

21 August 2017

author name string

Zhenhua Gao

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

3961334

retrieved

21 August 2017

Dianbin Mu

series ordinal

3

1 reference

stated in

Europe PubMed Central

PMC publication ID

3961334

retrieved

21 August 2017

publication date

13 February 2014

1 reference

stated in

Europe PubMed Central

PMC publication ID

3961334

retrieved

21 August 2017

published in

Oncology Letters

1 reference

stated in

Europe PubMed Central

PMC publication ID

3961334

retrieved

21 August 2017

volume

7

1 reference

stated in

Europe PubMed Central

PMC publication ID

3961334

retrieved

21 August 2017

issue

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

3961334

retrieved

21 August 2017

page(s)

1118-1122

1 reference

stated in

Europe PubMed Central

PMC publication ID

3961334

retrieved

21 August 2017

cites work

Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosis.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961334

retrieved

23 August 2017

The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961334

retrieved

23 August 2017

Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961334

retrieved

23 August 2017

Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961334

retrieved

23 August 2017

Current developments in the management of locally advanced esophageal cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961334

retrieved

6 September 2017

Expression of nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961334

retrieved

14 September 2017

Evaluation of prognostic factors of esophageal squamous cell carcinoma (stage II-III) after concurrent chemoradiotherapy using biopsy specimens

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961334

retrieved

14 September 2017

Prognosis of Esophageal Squamous Cell Carcinoma in Patients Positive for Human Epidermal Growth Factor Receptor Family Can Be Improved by Initial Chemotherapy with Docetaxel, Fluorouracil, and Cisplatin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961334

retrieved

25 June 2018

Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961334

retrieved

1 September 2018

Polymorphism in epidermal growth factor receptor intron 1 predicts prognosis of patients with esophageal cancer after chemoradiation and surgery.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961334

retrieved

1 September 2018

Squamous Cell Carcinoma of the Esophagus: Evaluation of the Status of Epidermal Growth Factor Receptors (EGFR and HER-2) by Immunohistochemistry and in Situ Hybridization

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961334

retrieved

1 September 2018

Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961334

retrieved

1 September 2018

Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961334

retrieved

1 September 2018

A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous rese

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961334

retrieved

1 September 2018

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961334

retrieved

1 September 2018

Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961334

retrieved

1 September 2018

Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24944678

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between laminin-5 gamma2 chain and epidermal growth factor receptor expression in esophageal squamous cell carcinomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24944678

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24944678

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24944678

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinicopathological and prognostic significance of EGFR over-expression in esophageal squamous cell carcinoma: a meta-analysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24944678

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24944678

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24944678

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.3892/OL.2014.1881

1 reference

stated in

Europe PubMed Central

PMC publication ID

3961334

retrieved

21 August 2017

PMC publication ID

3961334

1 reference

stated in

Europe PubMed Central

PMC publication ID

3961334

retrieved

21 August 2017

PubMed publication ID

24944678

1 reference

stated in

Europe PubMed Central

PMC publication ID

3961334

retrieved

21 August 2017

ResearchGate publication ID

263291600

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37652493&oldid=2175177370"